5F-MDMB-PICA
Synthetic cannabinoid
{{Drugbox
| verifiedrevid = 477318464
| IUPAC_name = Methyl 2-[[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino]-3,3-dimethylbutanoate
| image = 5F-MDMB-PICA_structure.png
| width = 200
| legal_uk = Class B
| legal_us = Schedule I
| legal_ca = Schedule II
| legal_de = Anlage II
| CAS_number = 1971007-92-7
| PubChem = 119025022
| ChemSpiderID = 52085000
| UNII = 7J1X0F7F3V
| C=20
| H=28
| F=1
| N=3
| O=3
| smiles = CC(C)(C)C(C(=O)OC)NC(=O)c1cn(CCCCC(F)F)c2c1cccc2
| StdInChI = 1S/C20H28FN3O3/c1-20(2,3)17(19(26)27-4)23-18(25)16-14-12-10-9-11-13(14)15(22-16)7-5-6-8-21/h9-12,17H,5-8H2,1-4H3,(H,22,23,25)
| StdInChIKey = QWZQXKZQXQXQXQ-UHFFFAOYSA-N
}}
5F-MDMB-PICA is a synthetic cannabinoid that has been used as an active ingredient in synthetic cannabis products. It is a potent agonist of the CB1 receptor and has been associated with numerous cases of severe toxicity and fatalities.
Chemical Structure and Properties
5F-MDMB-PICA is chemically classified as an indazole-based synthetic cannabinoid. Its IUPAC name is Methyl 2-[[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino]-3,3-dimethylbutanoate. The compound has a molecular formula of C20H28FN3O3 and a molecular weight of 377.46 g/mol.
Pharmacology
5F-MDMB-PICA acts as a potent agonist at the CB1 receptor, which is primarily responsible for the psychoactive effects of cannabinoids. The compound has a high binding affinity for the CB1 receptor, leading to strong psychoactive effects. It has been reported to cause severe adverse effects, including seizures, tachycardia, and acute kidney injury.
Legal Status
5F-MDMB-PICA is classified as a Schedule I controlled substance in the United States, indicating that it is considered to have a high potential for abuse and no accepted medical use. In the United Kingdom, it is classified as a Class B drug under the Misuse of Drugs Act 1971. It is also controlled under various international regulations.
Health Risks
The use of 5F-MDMB-PICA has been associated with numerous health risks. These include severe toxicity, psychosis, and death. The compound has been linked to multiple cases of overdose and has been found in various forensic toxicology reports.
Related Compounds
5F-MDMB-PICA is structurally related to other synthetic cannabinoids such as 5F-ADB, MDMB-CHMICA, and AB-FUBINACA. These compounds share similar pharmacological profiles and have been associated with similar adverse effects.
See Also
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD